Table 2.
Symptom severity of burnout, anxiety, distress, and depression measurements in total cohort and subgroups.
| Severity category | Total, N (%) | Sex, N (%) |
Age, N (%) |
Location, N (%) |
Prior psych. condition, N (%) |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Men | Women | p value | 25–44 | 45+ | p value | Southeast | Other | p value | Yes | No | p value | ||
| Mini-Z: burnout symptoms | |||||||||||||
| Negative | 139 (85.3) | 109 (90.1) | 30 (71.4) | 0.007 | 74 (81.3) | 65 (90.3) | 0.167 | 75 (82.4) | 64 (88.9) | 0.350 | 13 (72.2) | 126 (86.9) | 0.192 |
| Positive | 24 (14.7) | 12 (9.9) | 12 (28.6) | 17 (18.7) | 7 (9.7) | 16 (17.6) | 8 (11.1) | 5 (27.8) | 19 (13.1) | ||||
| GAD-7: anxiety symptoms | |||||||||||||
| Normal | 89 (54.6) | 73 (60.3) | 16 (38.1) | 0.001 | 39 (42.9) | 50 (69.4) | 0.005 | 46 (50.5) | 43 (59.7) | 0.595 | 4 (22.2) | 85 (58.6) | <0.0005 |
| Mild | 42 (25.8) | 32 (26.4) | 10 (23.8) | 27 (29.7) | 15 (20.8) | 27 (29.7) | 15 (20.8) | 2 (11.1) | 40 (27.6) | ||||
| Moderate | 19 (11.7) | 12 (9.9) | 7 (16.7) | 15 (16.5) | 4 (5.6) | 11 (12.1) | 8 (11.1) | 9 (50.0) | 10 (6.9) | ||||
| Severe | 13 (8.0) | 4 (3.3) | 9 (21.4) | 10 (11.0) | 3 (4.2) | 7 (7.7) | 6 (8.3) | 3 (16.7) | 10 (6.9) | ||||
| GAD-7: difficulty functioning | |||||||||||||
| Not difficult | 61 (37.4) | 53 (43.8) | 8 (19.0) | 0.001 | 26 (28.6) | 35 (48.6) | 0.036 | 33 (36.3) | 28 (38.9) | 0.971 | 2 (11.1) | 59 (40.7) | 0.065 |
| Somewhat difficult | 83 (50.9) | 55 (45.5) | 28 (66.7) | 52 (57.1) | 31 (43.1) | 47 (51.6) | 36 (50.0) | 12 (66.7) | 71 (49.0) | ||||
| Very difficult | 16 (9.8) | 13 (10.7) | 3 (7.1) | 10 (11.0) | 6 (8.3) | 9 (9.9) | 7 (9.7) | 3 (16.7) | 13 (9.0) | ||||
| Extremely difficult | 3 (1.8) | 0 (0.0) | 3 (7.1) | 3 (3.3) | 0 (0.0) | 2 (2.2) | 1 (1.4) | 1 (5.6) | 2 (1.4) | ||||
| IES-R: distress symptoms | |||||||||||||
| Subclinical | 120 (73.6) | 97 (80.2) | 23 (54.8) | 0.006 | 59 (64.8) | 61 (84.7) | 0.042 | 67 (73.6) | 53 (73.6) | 0.938 | 4 (22.2) | 116 (80.0) | <0.0005 |
| Clinical concern | 11 (6.7) | 6 (5.0) | 5 (11.9) | 8 (8.8) | 3 (4.2) | 7 (7.7) | 4 (5.6) | 3 (16.7) | 8 (5.5) | ||||
| Probable PTSD | 8 (4.9) | 6 (5.0) | 2 (4.8) | 6 (6.6) | 2 (2.8) | 4 (4.4) | 4 (5.6) | 1 (5.6) | 7 (4.8) | ||||
| Severe | 24 (14.7) | 12 (9.9) | 12 (28.6) | 18 (19.8) | 6 (8.3) | 13 (14.3) | 11 (15.3) | 10 (55.6) | 14 (9.7) | ||||
| PHQ-2: depression symptoms | |||||||||||||
| Negative | 137 (84.0) | 105 (86.8) | 32 (76.2) | 0.171 | 73 (80.2) | 64 (88.9) | 0.199 | 74 (81.3) | 63 (87.5) | 0.393 | 11 (61.1) | 126 (86.9) | 0.013 |
| Positive | 26 (16.0) | 16 (13.2) | 10 (23.8) | 18 (19.8) | 8 (11.1) | 17 (18.7) | 9 (12.5) | 7 (38.9) | 19 (13.1) | ||||
Abbreviations: GAD-7, 7-item Generalized Anxiety Disorder Scale; IES-R, Impact of Events Scale-Revised; IES-R “severe” level, probable PTSD with concern for immune suppression; PHQ-2, 2-item Patient Health Questionnaire.
Bold represents that it is statistically significant.